nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—type 1 diabetes mellitus	0.708	1	CbGaD
Lapatinib—TAP1—islet of Langerhans—type 1 diabetes mellitus	0.00526	0.1	CbGeAlD
Lapatinib—TAP1—nephron tubule—type 1 diabetes mellitus	0.00424	0.0807	CbGeAlD
Lapatinib—Gefitinib—ERBB3—type 1 diabetes mellitus	0.00409	0.628	CrCbGaD
Lapatinib—PIK3C2B—nephron tubule—type 1 diabetes mellitus	0.00398	0.0758	CbGeAlD
Lapatinib—TAP1—pancreas—type 1 diabetes mellitus	0.0037	0.0705	CbGeAlD
Lapatinib—PI4KB—islet of Langerhans—type 1 diabetes mellitus	0.0036	0.0685	CbGeAlD
Lapatinib—PIK3C2B—pancreas—type 1 diabetes mellitus	0.00347	0.0661	CbGeAlD
Lapatinib—PI4KB—nephron tubule—type 1 diabetes mellitus	0.0029	0.0552	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—type 1 diabetes mellitus	0.00278	0.0529	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—type 1 diabetes mellitus	0.00278	0.0529	CbGeAlD
Lapatinib—ERBB2—kidney—type 1 diabetes mellitus	0.00272	0.0518	CbGeAlD
Lapatinib—ERBB2—pancreas—type 1 diabetes mellitus	0.0027	0.0514	CbGeAlD
Lapatinib—PI4KB—kidney—type 1 diabetes mellitus	0.00255	0.0485	CbGeAlD
Lapatinib—PI4KB—pancreas—type 1 diabetes mellitus	0.00253	0.0482	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—type 1 diabetes mellitus	0.00233	0.0445	CbGeAlD
Lapatinib—Gefitinib—EGFR—type 1 diabetes mellitus	0.00184	0.282	CrCbGaD
Lapatinib—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000942	0.0179	CbGeAlD
Lapatinib—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000759	0.0145	CbGeAlD
Lapatinib—CYP2C8—kidney—type 1 diabetes mellitus	0.000739	0.0141	CbGeAlD
Lapatinib—CYP3A5—kidney—type 1 diabetes mellitus	0.000667	0.0127	CbGeAlD
Lapatinib—CYP3A5—pancreas—type 1 diabetes mellitus	0.000662	0.0126	CbGeAlD
Lapatinib—Gefitinib—ALB—type 1 diabetes mellitus	0.000585	0.0898	CrCbGaD
Lapatinib—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.0005	0.00953	CbGeAlD
Lapatinib—CYP3A4—kidney—type 1 diabetes mellitus	0.0005	0.00953	CbGeAlD
Lapatinib—ABCB1—retina—type 1 diabetes mellitus	0.000428	0.00815	CbGeAlD
Lapatinib—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000403	0.00768	CbGeAlD
Lapatinib—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000362	0.0069	CbGeAlD
Lapatinib—ABCB1—kidney—type 1 diabetes mellitus	0.000354	0.00675	CbGeAlD
Lapatinib—ABCB1—pancreas—type 1 diabetes mellitus	0.000352	0.0067	CbGeAlD
Lapatinib—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.000335	0.0496	CcSEcCtD
Lapatinib—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000317	0.0469	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000304	0.00579	CbGeAlD
Lapatinib—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00025	0.037	CcSEcCtD
Lapatinib—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000234	0.0346	CcSEcCtD
Lapatinib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000232	0.0344	CcSEcCtD
Lapatinib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000225	0.0333	CcSEcCtD
Lapatinib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000225	0.0333	CcSEcCtD
Lapatinib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00021	0.0311	CcSEcCtD
Lapatinib—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000193	0.0286	CcSEcCtD
Lapatinib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000193	0.0285	CcSEcCtD
Lapatinib—Alopecia—Ramipril—type 1 diabetes mellitus	0.000189	0.028	CcSEcCtD
Lapatinib—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000187	0.0277	CcSEcCtD
Lapatinib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000186	0.0276	CcSEcCtD
Lapatinib—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000167	0.0247	CcSEcCtD
Lapatinib—Palpitations—Ramipril—type 1 diabetes mellitus	0.000165	0.0244	CcSEcCtD
Lapatinib—Cough—Ramipril—type 1 diabetes mellitus	0.000163	0.024	CcSEcCtD
Lapatinib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000159	0.0235	CcSEcCtD
Lapatinib—Myalgia—Ramipril—type 1 diabetes mellitus	0.000159	0.0235	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000157	0.0233	CcSEcCtD
Lapatinib—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000152	0.0225	CcSEcCtD
Lapatinib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000149	0.0221	CcSEcCtD
Lapatinib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000148	0.0218	CcSEcCtD
Lapatinib—Anorexia—Ramipril—type 1 diabetes mellitus	0.000145	0.0214	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000139	0.0205	CcSEcCtD
Lapatinib—Insomnia—Ramipril—type 1 diabetes mellitus	0.000137	0.0203	CcSEcCtD
Lapatinib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000136	0.02	CcSEcCtD
Lapatinib—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000134	0.0198	CcSEcCtD
Lapatinib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000132	0.0195	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000131	0.0194	CcSEcCtD
Lapatinib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000131	0.0194	CcSEcCtD
Lapatinib—Constipation—Ramipril—type 1 diabetes mellitus	0.00013	0.0192	CcSEcCtD
Lapatinib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000124	0.0184	CcSEcCtD
Lapatinib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00012	0.0178	CcSEcCtD
Lapatinib—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000112	0.0166	CcSEcCtD
Lapatinib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000109	0.0161	CcSEcCtD
Lapatinib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000108	0.0159	CcSEcCtD
Lapatinib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000104	0.0154	CcSEcCtD
Lapatinib—Vomiting—Ramipril—type 1 diabetes mellitus	9.67e-05	0.0143	CcSEcCtD
Lapatinib—Rash—Ramipril—type 1 diabetes mellitus	9.59e-05	0.0142	CcSEcCtD
Lapatinib—Dermatitis—Ramipril—type 1 diabetes mellitus	9.58e-05	0.0142	CcSEcCtD
Lapatinib—Headache—Ramipril—type 1 diabetes mellitus	9.52e-05	0.0141	CcSEcCtD
Lapatinib—Nausea—Ramipril—type 1 diabetes mellitus	9.03e-05	0.0134	CcSEcCtD
Lapatinib—EGFR—Signaling by FGFR—IL6—type 1 diabetes mellitus	2.79e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	2.79e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—type 1 diabetes mellitus	2.78e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—type 1 diabetes mellitus	2.77e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—type 1 diabetes mellitus	2.77e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS2—type 1 diabetes mellitus	2.77e-05	0.000122	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	2.75e-05	0.000121	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	2.74e-05	0.000121	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD80—type 1 diabetes mellitus	2.72e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—type 1 diabetes mellitus	2.72e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Disease—B2M—type 1 diabetes mellitus	2.72e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.72e-05	0.00012	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	2.7e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD80—type 1 diabetes mellitus	2.68e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—type 1 diabetes mellitus	2.68e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.67e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GCG—type 1 diabetes mellitus	2.62e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—INS—type 1 diabetes mellitus	2.62e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CD86—type 1 diabetes mellitus	2.61e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.61e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	2.6e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	2.6e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—type 1 diabetes mellitus	2.6e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DPB1—type 1 diabetes mellitus	2.6e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—type 1 diabetes mellitus	2.58e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CD86—type 1 diabetes mellitus	2.58e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.57e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB2—Disease—INS—type 1 diabetes mellitus	2.57e-05	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-E—type 1 diabetes mellitus	2.56e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	2.56e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GAL—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—STAT3—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	2.54e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB4—Disease—INS—type 1 diabetes mellitus	2.53e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	2.53e-05	0.000111	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.51e-05	0.000111	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.51e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TYK2—type 1 diabetes mellitus	2.49e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.48e-05	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTLA4—type 1 diabetes mellitus	2.47e-05	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.45e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TYK2—type 1 diabetes mellitus	2.45e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD80—type 1 diabetes mellitus	2.45e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.45e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.44e-05	0.000108	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	2.41e-05	0.000106	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—type 1 diabetes mellitus	2.37e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.36e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.36e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—type 1 diabetes mellitus	2.35e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD80—type 1 diabetes mellitus	2.35e-05	0.000104	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	2.35e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TYK2—type 1 diabetes mellitus	2.34e-05	0.000103	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—type 1 diabetes mellitus	2.33e-05	0.000103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.32e-05	0.000102	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.32e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PRKCQ—type 1 diabetes mellitus	2.31e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	2.3e-05	0.000102	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TYK2—type 1 diabetes mellitus	2.3e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—type 1 diabetes mellitus	2.3e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.29e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.28e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS1—type 1 diabetes mellitus	2.28e-05	0.0001	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TYK2—type 1 diabetes mellitus	2.26e-05	9.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	2.26e-05	9.99e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS3—type 1 diabetes mellitus	2.26e-05	9.96e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—type 1 diabetes mellitus	2.25e-05	9.94e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.25e-05	9.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—VAV1—type 1 diabetes mellitus	2.24e-05	9.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.23e-05	9.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS3—type 1 diabetes mellitus	2.22e-05	9.81e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—type 1 diabetes mellitus	2.22e-05	9.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	2.21e-05	9.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	2.2e-05	9.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQA1—type 1 diabetes mellitus	2.17e-05	9.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PRKCQ—type 1 diabetes mellitus	2.13e-05	9.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.12e-05	9.35e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	2.11e-05	9.29e-05	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—type 1 diabetes mellitus	2.09e-05	9.23e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—type 1 diabetes mellitus	2.08e-05	9.18e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—type 1 diabetes mellitus	2.08e-05	9.18e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—type 1 diabetes mellitus	2.07e-05	9.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—VAV1—type 1 diabetes mellitus	2.07e-05	9.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TYK2—type 1 diabetes mellitus	2.07e-05	9.12e-05	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—type 1 diabetes mellitus	2.06e-05	9.09e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—type 1 diabetes mellitus	2.05e-05	9.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—type 1 diabetes mellitus	2.05e-05	9.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—type 1 diabetes mellitus	2.04e-05	9.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQB1—type 1 diabetes mellitus	2.03e-05	8.96e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	2.01e-05	8.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.99e-05	8.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.98e-05	8.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.98e-05	8.74e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	1.96e-05	8.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD86—type 1 diabetes mellitus	1.95e-05	8.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—type 1 diabetes mellitus	1.92e-05	8.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	1.92e-05	8.46e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.91e-05	8.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.9e-05	8.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—type 1 diabetes mellitus	1.9e-05	8.37e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.88e-05	8.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.87e-05	8.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—type 1 diabetes mellitus	1.87e-05	8.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-B—type 1 diabetes mellitus	1.82e-05	8.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD86—type 1 diabetes mellitus	1.8e-05	7.97e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—INS—type 1 diabetes mellitus	1.8e-05	7.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—type 1 diabetes mellitus	1.8e-05	7.92e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—INS—type 1 diabetes mellitus	1.78e-05	7.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—type 1 diabetes mellitus	1.77e-05	7.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB3—type 1 diabetes mellitus	1.76e-05	7.78e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—STAT3—type 1 diabetes mellitus	1.74e-05	7.7e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.74e-05	7.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SST—type 1 diabetes mellitus	1.74e-05	7.68e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	1.74e-05	7.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.73e-05	7.64e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—STAT3—type 1 diabetes mellitus	1.72e-05	7.58e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.72e-05	7.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2RA—type 1 diabetes mellitus	1.71e-05	7.54e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	1.69e-05	7.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-A—type 1 diabetes mellitus	1.69e-05	7.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—STAT3—type 1 diabetes mellitus	1.64e-05	7.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB3—type 1 diabetes mellitus	1.63e-05	7.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—type 1 diabetes mellitus	1.61e-05	7.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.61e-05	7.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—STAT3—type 1 diabetes mellitus	1.61e-05	7.1e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	1.61e-05	7.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—type 1 diabetes mellitus	1.6e-05	7.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—type 1 diabetes mellitus	1.6e-05	7.06e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	1.59e-05	7.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.59e-05	7e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—STAT3—type 1 diabetes mellitus	1.59e-05	7e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	1.59e-05	6.99e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—type 1 diabetes mellitus	1.58e-05	6.99e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.58e-05	6.97e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—type 1 diabetes mellitus	1.56e-05	6.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HLA-A—type 1 diabetes mellitus	1.56e-05	6.88e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.56e-05	6.87e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	1.56e-05	6.87e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	1.55e-05	6.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GCG—type 1 diabetes mellitus	1.55e-05	6.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.54e-05	6.81e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.53e-05	6.76e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.51e-05	6.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.49e-05	6.59e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	1.47e-05	6.48e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—type 1 diabetes mellitus	1.46e-05	6.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.45e-05	6.4e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	1.45e-05	6.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.45e-05	6.38e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—type 1 diabetes mellitus	1.44e-05	6.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD80—type 1 diabetes mellitus	1.43e-05	6.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—type 1 diabetes mellitus	1.42e-05	6.26e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	1.38e-05	6.1e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	1.37e-05	6.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	1.36e-05	6.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—type 1 diabetes mellitus	1.36e-05	5.99e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	1.35e-05	5.95e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.34e-05	5.92e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.34e-05	5.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.32e-05	5.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.32e-05	5.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.32e-05	5.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD80—type 1 diabetes mellitus	1.32e-05	5.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.31e-05	5.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	1.31e-05	5.78e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.28e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CD86—type 1 diabetes mellitus	1.26e-05	5.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—INS—type 1 diabetes mellitus	1.24e-05	5.49e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.24e-05	5.48e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	1.24e-05	5.47e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	1.23e-05	5.44e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	1.23e-05	5.41e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—type 1 diabetes mellitus	1.22e-05	5.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TYK2—type 1 diabetes mellitus	1.2e-05	5.31e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.2e-05	5.31e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	1.2e-05	5.31e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—type 1 diabetes mellitus	1.2e-05	5.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.2e-05	5.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.2e-05	5.28e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.18e-05	5.21e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.17e-05	5.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—type 1 diabetes mellitus	1.14e-05	5.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.14e-05	5.03e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.13e-05	4.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—type 1 diabetes mellitus	1.13e-05	4.98e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—type 1 diabetes mellitus	1.12e-05	4.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.12e-05	4.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TYK2—type 1 diabetes mellitus	1.11e-05	4.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.11e-05	4.9e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.11e-05	4.9e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—type 1 diabetes mellitus	1.11e-05	4.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.1e-05	4.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.1e-05	4.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—type 1 diabetes mellitus	1.09e-05	4.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—type 1 diabetes mellitus	1.09e-05	4.8e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	1.07e-05	4.74e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	1.05e-05	4.63e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.03e-05	4.54e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.02e-05	4.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—type 1 diabetes mellitus	1.01e-05	4.46e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.01e-05	4.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—type 1 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—type 1 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—type 1 diabetes mellitus	1e-05	4.42e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	9.59e-06	4.23e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	9.36e-06	4.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	9.33e-06	4.12e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CD80—type 1 diabetes mellitus	9.22e-06	4.07e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	9.09e-06	4.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INS—type 1 diabetes mellitus	8.71e-06	3.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—type 1 diabetes mellitus	8.43e-06	3.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.43e-06	3.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	8.12e-06	3.58e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	7.92e-06	3.5e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	7.88e-06	3.48e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—type 1 diabetes mellitus	7.87e-06	3.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.78e-06	3.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—type 1 diabetes mellitus	7.78e-06	3.43e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—type 1 diabetes mellitus	7.76e-06	3.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.64e-06	3.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.41e-06	3.27e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.37e-06	3.25e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	7.24e-06	3.19e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	6.97e-06	3.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.49e-06	2.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—type 1 diabetes mellitus	6.48e-06	2.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.44e-06	2.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	6.39e-06	2.82e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	6.11e-06	2.7e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	6.04e-06	2.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—type 1 diabetes mellitus	5.89e-06	2.6e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	5.77e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	5.53e-06	2.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.45e-06	2.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—type 1 diabetes mellitus	5.44e-06	2.4e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	5.39e-06	2.38e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	5.29e-06	2.34e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.26e-06	2.32e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	4.94e-06	2.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.88e-06	2.15e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	4.82e-06	2.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	4.73e-06	2.09e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.61e-06	2.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—type 1 diabetes mellitus	3.81e-06	1.68e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.24e-06	1.43e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.97e-06	1.31e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.84e-06	1.25e-05	CbGpPWpGaD
